p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab

Patrizia Vici, Francesca Sperati, Marcello Maugeri-Saccà, Elisa Melucci, Anna Di Benedetto, Luigi Di Lauro, Laura Pizzuti, Domenico Sergi, Irene Terrenato, Luca Esposito, Carmelina Antonella Iannuzzi, Raffaella Pasquale, Claudio Botti, Barbara Fuhrman, Antonio Giordano, Marcella Mottolese, Maddalena Barba*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab'. Together they form a unique fingerprint.

Medicine & Life Sciences